[Azoreductase in neoplastic liver tissue. II. Variations during oncogenesis and the effect of treatment with flavin].
D063646:Carcinogenesis; D005415:Flavins; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism*; D016660:NAD(P)H Dehydrogenase (Quinone); D009247:NADH, NADPH Oxidoreductases; D009601:Nitroreductases; D010088:Oxidoreductases / Q000378:metabolism*; D012256:Riboflavin / Q000494:pharmacology*
D005415:Flavins; D010088:Oxidoreductases; D009247:NADH, NADPH Oxidoreductases; D016660:NAD(P)H Dehydrogenase (Quinone); C447479:NQO1 protein, human; D009601:Nitroreductases; C021106:azoreductase; D012256:Riboflavin
DEHYDROGENASES/metabolism; LIVER NEOPLASMS/metabolism; VITAMIN B 2/pharmacology